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Abstract. Penile tumors represent a difficult group of 
neoplasms requiring effective and curative treatment 
while minimizing tissue loss to prevent cosmetic and 
functional deformity. Over the past 6 years, we have 
treated 20 patients with penile cancer utilizing the fresh 
tissue technique of Mohs micrographic surgery. Tumors ' were excised with an average of 2.25 stages. Most defects 
(80%) were allowed to heal by second intention. Since 
surgery, four patients have developed metastatic disease 
in their regional lymphatic system, and one patient has 
died from metastatic spread. One patient has developed 
local recurrence. Micrographic surgery is a very useful 
treatment modality for patients with penile tumors. Pa- 
tients with SCC of the penis should be considered for. 
elective regional lymph node biopsy and/or dissection in 
conjunction with micrographically controlled excision of 
the primary tumor. 
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FIRST PRIZE 
INTRODUCTION 
Surgical treatment of penile carcinoma has primar- 
ily been the domain of the urologist. The traditional 
surgical approach for penile malignancies (most 
commonly squamous in origin) has been partial or 
total penectomy, either with or without ilioinguinal 
lymphoadenectomy. ' r 2  This surgical approach often 
results in marked cosmetic deformity of the penis, 
with impaired sexual function and body image. 
As the benefits of Mohs micrographic surgery be- 
come established, there is an increasing tendency 
for patients with penile tumors to be referred for 
treatment by this technique. Mohs surgery offers 
the unique advantages of effective surgical treat- 
ment with microscopically controlled tumor-free 
borders while maintaining cosmetic and functional 
demands by maximal preservation of normal tissue. 
The purpose of this paper is to present our expe- 
rience over the past 6 years in treating penile neo- 
plasms with the Mohs technique. In doing so, we 
hope to emphasize the advantages of this surgical 
approach as the preferred treatment modality for 
localized penile carcinomas. 
MATERIALS AND METHODS 
Twenty patients with penile cancers were treated 
by the fresh-tissue technique of Mohs micrographic 
surgery at the University of Michigan's Department 
of Cutaneous Surgery and Oncology between 1981 
and 1987. Preoperative evaluation included the size 
and location of the penile tumor, bilateral palpation 
of femoral and inguinal lymph nodes, and careful 
inspection of the scrotum and base of the penis to 
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FIGURE 1. SCC on the glans penis, preoperatively. 
rule out local extension. All patients were evaluated 
concurrently by a urologist. The patients were clin- 
ically examined during the early postoperative pe- 
riod, and subsequently followed by us or their re- 
ferring physician. Their progress and clinical 
outcome was reviewed by examination of inpatient 
and outpatient hospital records, as well as by tele- 
phone survey. Mean follow-up was approximately 
3 years for 17 patients; three patients were lost to 
Mohs surgery was performed in an outpatient 
setting in the standard fashion. Local anesthesia 
was achieved with a Carbocaine block. A tourni- 
quet was placed at the base of the penis to minimize 
bleeding. A foley catheter was inserted for patient 
comfort and to serve as an anatomic landmark for 
the urethra and meatus (Fig. 1). Due to the con- 
tractile nature of the penile tissue, marking sutures 
were used to identify the margins of the sections 
instead of the conventional method of scoring the 
tissue with a scalpel blade. Hemostasis was ob- 
tained with several modalities, including use of a 
Bovie, spot electrocautery, pressure, and gelfoam. 
The average age of our patient population was 
55 years, with a range of 35 to 80 years. Histologi- 
cally, eleven patients had squamous cell carcinoma 
(SCC), seven patients had Bowen’s squamous in- 
traepidermal neoplasia, one patient had a verru- 
cous carcinoma, and one patient had a leiomyosar- 
coma. Sixteen tumors were confined to the glans 
penis, and four were located on the distal shaft. 
There were no palpable nodes at the time of sur- 
gery, and there was no clinical extention to the 
follow-up. 
FIGURE 2. Healing by second intention 2 weeks post- 
operatively. 
scrotum or base of the penis. Four of these referral 
cases were recurrent tumors, having been treated 
elsewhere by non-Mohs therapy. Preexisting con- 
ditions were seen in four patients; three patients 
with SCC had a previous diagnosis of balanitis xe- 
rotica obliterans (BXO), and the one patient with a 
leiomyosarcoma had sustained a previous trau- 
matic event to the penis. Tumor size ranged from 
0.5 x 0.5 to 6.0 x 5.0 cm with an average size of 
2.3 x 1.8 cm. 
RESULTS 
All patients tolerated the surgery well in an out- 
patient setting with no significant perioperative or 
postoperative complications. Tumor excision was 
complete in nineteen patients with an average of 
2.25 stages. The average postoperative defect size 
was 3.6 x 3.0 cm, with the largest defect being 6.0 
x 7.0 cm. Most defects (16 patients) were allowed 
to heal by second intention (Fig. 2), three were 
closed primarily, and one was referred to the urol- 
ogy service for closure and repair. 
Of the seventeen patients reviewed, only one 
has possibly developed local recurrence. Four pa- 
tients with SCC were subsequently found to have 
positive regional nodes, despite being clinically 
negative at the time of surgery. One patient has 
died of metastatic disease, and one patient has died 
from unrelated medical causes. Two of the four pa- 
tients with metastatic disease and the one patient 
with local recurrence had a preexisting diagnosis of 
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BXO. Although the number of patients is small, 
BXO appeared to be a poor prognostic indicator. 
DISCUSSION 
Penile malignancies account for less than 1% of 
male cancers in the U.S.3*4 There is an estimated 1 
to 2 new cases per 10,000 population per year.4 
Early circumcision and proper hygiene probably ac- 
count for this low U.S. incidence, especially when 
compared to underdeveloped countries. In certain 
African and Asian populations, where circumcision 
is uncommon, penile carcinoma accounts for 10 to 
20% of all malignancies in males.4 The development 
of penile cancer among uncircumcised males has 
been associated with the chronic, irritative effects 
of smegma, the by-product of bacterial action on 
desquamated cells that is retained within the pre- 
putial sac. Although smegma has been identified as 
a carcinogen in animal models, the specific com- 
ponent responsible for malignant degeneration in 
human males has not been identified.3 Adult cir- 
umcision appears to offer little or no protection 
against the future appearance of penile tumors. 
Penile cancers rarely develop in males circum- 
cised in the neonatal period, but becomes more fre- 
quent when circumcision is delayed until puberty. 
No consistent etiologic relationship has been estab- 
lished for antecedent trauma and/or venereal dis- 
ease. Precancerous lesions include leukoplakia, 
BXO, and the Buschke-Lowenstein tumor. Erytho- 
plasia of Querat and Bowen's disease are consid- 
ered to be carcinomas in situ, and are histologically 
identical. 
Penile carcinoma is usually seen in the 6th to 7th 
decade, but is not uncommon in the 4th to 5th. In 
our population, the mean age was 55 years. The 
tumor is most common on the glans, prepuce, or 
coronal sulcus, and much less common on the shaft 
or meatus. Common presenting symptoms include 
the presence of a tumor mass or phimosis of recent 
onset. The cancer may appear indurated and ery- 
thematous, warty and exophytic, or flat and ulcer- 
ated. All these tumors appear to have a similar rate 
of growth, but the ulcerative lesion has a tendency 
towards earlier nodal metastases. Initially, the phi- 
mosis may obscure the tumor mass and result in a 
delayed diagnosis. Eventually, a foul odor, dis- 
charge, and bleeding may occur. At times, inguinal 
adenopathy may be the presenting symptom. Pain 
is not a common symptom, even with extensive lo- 
cal destruction. Likewise, urinary symptoms are 
uncommon unless the tumor is far advanced with 
resultant autoamputation. 
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Unfortunately, many lesions are quite advanced 
at the time of diagnosis. Possibly due to fear of pen- 
ile surgery, as high as 50% of patients delay medical 
care for greater than 1 year.3 Penile cancer has a 
relentless progressive course with death in approx- 
imately 2 years if untreated. Death usually results 
from uncontrolled regional lymphatic spread lead- 
ing to skin necrosis, chronic infection, debilitation, 
and sepsis. 
Because carcinoma of the penis is uncommon in 
the U.S., there has been a relative scarcity of well- 
controlled, prospective studies concerning the 
proper treatment of this cancer. Controversy in 
disease management includes the appropriate sur- 
gical treatment of the primary lesion and the sub- 
sequent evaluation and treatment of nodal disease. 
Selected small tumors that are limited to the pre- 
puce have been treated by circumcision alone. 
However, tumor recurrence can be unacceptably 
high, with reports of a 40 to 50% recurrence rate.3,4 
For tumors on the glans and distal shaft, partial 
amputation with a 2-cm proximal margin is rec- 
ommended. For more extensive lesions or those 
located on the proximal shaft, total penectomy is 
performed. 
The desired goal in the treatment of the primary 
tumor is complete excision with adequate tumor- 
free margins. Mohs micrographic surgery allows 
the precise identification of these tumor-free mar- 
gins, while minimizing tissue loss. It is an excellent 
alternative to the traditional surgical approach of 
partial or total penectomy. 
Microscopically controlled chemosurgery was 
introduced in 1941 by Frederic M ~ h s . ~  A fixation 
process with zinc chloride paste was utilized to re- 
move thin layers of tissue which were sequentially 
examined microscopically for evidence of tumor. 
This procedure was continued, sometimes over a 
period of days, until tumor-free margins were de- 
fined. In 1985, Mohs summarized his results with 
the fixed tissue technique in the treatment of SCC 
of the penise6 He treated 29 patients with a follow- 
up  of at least 5 years in 25 cases. The primary car- 
cinoma was eradicated in 23 patients (92%) with a 
5-year cure rate of 68%. The cure rate was highest 
for the more distally located carcinomas. There was 
an 81% cure rate when the tumor was localized to 
the glans and/or prepuce, but only a 57% cure rate 
when the penile shaft was involved. The size of the 
penile lesion also affected prognosis, with a 100% 
cure rate if less than 1.0 cm, but only a 50% cure if 
greater than 3.0 cm. 
Other poor prognostic indicators included nodal 
metastases at the time of surgery and previous 
treatment of the primary tumor by conventional 
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surgery or radiation therapy. None of the patients 
treated by Mohs reported a functional deficit, either 
sexual or urinary. Mohs concluded that except for 
large and highly anaplastic tumors, which would 
preclude preservation of a functional penis, and 
those on the foreskin, which could be excised com- 
pletely by circumcision, microscopically controlled 
surgery was the preferred surgical technique for 
treatment of localized penile carcinomas. 
The fresh tissue technique of micrographic sur- 
gery was popularized in the 1970s by Stegman and 
T r o m ~ v i c h . ~  This approach required the surgical 
excision of fresh, unfixed tissue with subsequent 
analysis of cryostat sections. The fresh tissue tech- 
nique is far more rapid and precise and has largely 
replaced the fixed tissue technique. All of our pa- 
tients were treated with the fresh tissue technique. 
Although we cannot yet quote a 5-year survival 
rate, our results to date have been very satisfactory 
and encouraging. Only one patient has developed 
a local recurrence, and it is possible that this rep- 
resents a second primary lesion. Five to fifteen per- 
cent of patients with penile cancer develop a second 
primary tumor.4 Our patient had a long standing 
history of extensive BXO, with a second tumor de- 
veloping 4 years after the primary surgery. With the 
preexisting condition of BXO and the relatively long 
period of time elapsed between tumors, it is likely 
that this tumor may be a second primary SCC of 
the penis. 
Four of our patients have developed metastatic 
spread to the inguinal nodes, and one of these pa- 
tients has died from his metastatic disease. This 
was 20% of our total population and 35% of the 
patients with SCC (including the three patients lost 
to follow-up). Metastatic spread was not suspected 
clinically at the time of surgery, which was a sur- 
prising finding in that an estimated 50% of patients 
present with inguinal adenopathy at the time of 
diagnosis. In all cases, metastatic involvement was 
diagnosed within 1 year postsurgery. The earliest 
route of spread of penile cancer is metastases to the 
regional femoral and iliac lymph nodes. There are 
multiple cross communications throughout all lev- 
els of penile lymphatic drainage such that drainage 
is bilateral to both inguinal areas. In spite of the 
rich blood supply of the penis and possible spread 
through the pelvic vasculature, visceral metastases 
are rare. Clinically detectable distant metastases to 
lung, liver, bone, and brain occur in less than 10% 
of patients, usually late in the course of the disease. 
Our 20% incidence of metastatic disease raises 
the controversy of proper management of regional 
lymph nodes with penile cancer. Approximately 1/3 
of patients presenting with penile carcinoma have 
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metastatic spread to the regional inguinal lymph 
nodes.' Because 40 to 50% of patients with positive 
nodes can be cured by node dissection, it is impor- 
tant to diagnose and treat this metastatic spread in 
a timely fashion. Unfortunately, clinical evaluation 
is imprecise and inaccurate with unacceptable false 
positive and false negative rates. It has been esti- 
mated that as high as 50% of patients with clinically 
positive nodes have no metastatic disease on his- 
tologic examination while 20% of patients with clin- 
ically negative nodes have occult To 
further complicate the issue, approximately 10% of 
patients with clinically positive nodes that are nega- 
tive on node biopsy subsequently will demonstrate 
regional d i s e a ~ e . ~  Although bilateral prophylactic 
inguinal lymphadenectomy is potentially curative 
and is the most accurate diagnostic staging proce- 
dure, it carries a significant incidence of morbidity, 
including wound infection, skin flap necrosis, pul- 
monary emboli, and chronic lymphedema.3,'3 
Johnson and Lol4 compared patients who had 
late versus early node dissection and found a sig- 
nificant difference in mortality (57 vs. 13% 5-year 
survival). Therefore, the diagnostic challenge is to 
identify which patients have metastatic spread and 
to therapeutically dissect the involved nodes as 
early as possible. Some authors recommend 
"watchful waiting" if the regional nodes are clini- 
cally negative, especially if the primary tumor is 
small and located distally on the glans or pre- 
p ~ c e . ~ , ' ~  Others have strongly recommended bilat- 
eral sentinel node biopsies, regardless of whether 
the nodes are clinically i n ~ o l v e d . ' ~ ' ~ ~ ' ~  This recom- 
mendation is based on lymphangiographic evi- 
dence that a sentinel node located near the junction 
of the saphenous and femoral veins is the first site 
of metastatic spread from a penile cancer.15 
The sensitivity of this diagnostic procedure has 
been estimated to be 88%.' If the sentinel node is 
positive, then a bilateral deep and superficial ilio- 
inguinal node dissection is warranted. If the sen- 
tinel node is negative, no further surgery is rec- 
ommended. However, close clinical follow-up and 
observation (preferably by the same physician) for 
the appearance of unrecognized inguinal metas- 
tases in biopsy negative patients is mandatory. 
There have been several reports of patients with 
false negative sentinel node biopsies who subse- 
quently developed metastatic spread.',12 Nonethe- 
less, the sentinel node biopsy, because of its sim- 
plicity and low morbidity, is an attractive method 
for staging apparently localized penile cancer. The 
role of the sentinel node biopsy requires continued 
assessment, as well as establishment of its true sen- 
sitivity and specificity. 
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An alternate proposal is that of a bilateral super- 
ficial node dissection. This involves removal of 
those nodes superficial to the fascia lata with pro- 
gression to total lymphadenectomy (including 
nodes deep to the fascia lata contained within the 
femoral triangle) if the superficial nodes are posi- 
t i ~ e . ~  This approach is based on the fact that iliac 
lymph nodes rarely become involved unless metas- 
tases have first reached the superficial inguinal 
nodes. 
Finally, some urologists recommend bilateral 
prophylactic and therapeutic ilioinguinal node dis- 
sections for penile cancers.',I6 This approach offers 
the best chance of cure, but its usefulness is limited 
by the morbidity of the procedure and the lack of 
controlled prospective studies to substantiate its 
benefit.I4 Its best indication may be for large tumors 
located more proximally on the penile shaft in as- 
sociation with convincing clinical evidence of lym- 
phatic involvement.' 
Our experience of nodal metastases with clini- 
cally negative nodes at the time of primary surgery 
in 36% patients with SCC of the penis would sug- 
gest a more aggressive diagnostic approach than a 
"watch and wait" policy. In view of the high inci- 
dence of lymph node metastases and the probable 
need for sentinel node biopsy, superficial node dis- 
section or complete ilioinguinal node dissection, it 
is imperative that a urologist be a member of the 
treatment team. 
SUMMARY 
Our experience with 20 patients with penile cancer 
treated by micrographic surgery has been encour- 
aging. Mohs surgery has several distinct advan- 
tages. First and foremost, it is a pricise surgical ap- 
proach for the removal of the primary penile tumor, 
with a surgical field microscopically free of invasive 
tumor or marked dysplastic changes. It offers com- 
parable survival rates with a less radical procedure 
and may often be curative. Through preservation 
of penile tissue, there is considerable cosmetic 
benefit and maintenance of normal sexual function. 
Surgery is well tolerated with the use of local anes- 
thesia in an outpatient setting with negligible mor- 
bidity and high patient acceptance. Follow-up over 
ensuing years is necessary to define the 5-year sur- 
vival rate. In the future, closer attention to the 
depth of invasion, histologic differentiation and in- 
travascular involvement may help to better define 
prognosis. Our experience and that of others indi- 
cates the potential need for sentinel node biopsy 
and/or lymphadenectomy at the time of primary 
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